Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2005-03-31 | Two directors have chosen not to stand for re-election: Mr. Bailey and Mr. Hoese. The Board has nominated two individuals, Michael D. Sholtis and T. Jefferson Straub, to fill these openings. All directors who are not also employees of the Company receive $12,000 annually. |
| 2006-02-21 | Michael D. Sholtis, 58, Director (Independent). The Audit Committee consisted of Mr. Straub, Mr. Price, and Mr. Sholtis. The Compensation Committee consisted of Mr. Price and Mr. Sholtis. The Corporate Governance and Nominating Committee consists of Mr. Price, Mr. Sholtis, and Mr. Straub. Mr. Sholtis is an independent director. |
| 2007-08-01 | Michael D. Sholtis 59 Director ... Our board of directors has a standing audit committee, corporate governance and nominating committee, and compensation committee. ... Audit Committee Price, Sholtis, and Straub ... Corporate Governance and Nominating Committee Price, Sholtis, and Straub ... Compensation Committee Price and Sholtis ... All directors who are not also our employees receive $24,000 annually ... |
| 2008-02-19 | Michael D. Sholtis 59 Director The members of each of the committees of our board of directors and the number of times they met during fiscal year 2007 is set forth below: Audit Committee Price, Sholtis, and Straub Corporate Governance and Nominating Committee Price, Sholtis, and Straub Compensation Committee Price and Sholtis All directors who are not employees of the Company receive $24,000 annually, plus $1,000 for attendance at each board of directors and committee meeting, and reimbursement of reasonable expenses. The $1,000 fee is not paid for attendance at a committee meeting that is held the same day the board of directors meets nor for participation in any meeting telephonically. Effective December 18, 2006, our board of directors approved a grant of options to all non employee directors. Each non-employee director received options to purchase 25,000 shares of our common stock exercisable at a price of $4.79 per share. The options vest 25% on the date of grant and then an additional 2.08% per month for each of the thirty six calendar months beginning on the one year anniversary of the date of grant, provided that the director continues to serve on our board of directors. |
Data sourced from SEC filings. Last updated: 2025-08-30